Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-EN Version v4-FR
Language English French
Date Updated 2022-05-21 2022-01-07
Drug Identification Number 02248239 02248239
Brand name ELIGARD ELIGARD
Common or Proper name Leuprolide acetate for injection Leuprolide acetate for injection
Company Name TOLMAR INTERNATIONAL LTD. TOLMAR INTERNATIONAL LTD.
Ingredients LEUPROLIDE ACETATE LEUPROLIDE ACETATE
Strength(s) 7.5MG 7.5MG
Dosage form(s) POWDER FOR SUSPENSION, EXTENDED-RELEASE POWDER FOR SUSPENSION, EXTENDED-RELEASE
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 Carton / Kit 1 Carton / Kit
ATC code L02AE L02AE
ATC description HORMONES AND RELATED AGENTS HORMONES AND RELATED AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-01-21 2022-01-21
Actual start date 2022-01-24
Estimated end date 2022-06-10 2022-02-14
Actual end date 2022-05-20
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments ELIGARD® 22.5 mg, 30 mg and 45 mg are available. ELIGARD® 22.5 mg, 30 mg and 45 mg are available.
Health Canada comments